ArticleFrontiers in immunology2022

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.

Matthew P Lennol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.